2014
DOI: 10.1007/s00467-014-2996-z
|View full text |Cite
|
Sign up to set email alerts
|

Chronic kidney disease in disadvantaged populations

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
8
1

Year Published

2015
2015
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(10 citation statements)
references
References 43 publications
0
8
1
Order By: Relevance
“…The differences in the study population, lifestyle of study participants, sample size, or differences in availability of health-care services and utilization may also contribute to the differences. 9…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…The differences in the study population, lifestyle of study participants, sample size, or differences in availability of health-care services and utilization may also contribute to the differences. 9…”
Section: Discussionmentioning
confidence: 99%
“…8 Even though, CKD is misconceived as a disease of affluent, developed, and developing nations, it is emerging in several low-income countries, resulting in a double burden on the population. 9,10 In these low-resource settings, end-stage renal disease is often a death sentence for a lot of people since renal replacement therapy is often unavailable or unaffordable. 11 The global increase in CKD is linked to its leading causes, mainly, diabetes mellitus (DM) and hypertension, and risk factors like family history of CKD, aging, and HIV/AIDS.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, there are still many gaps to be filled in the knowledge of the characteristics of Brazilian children with ESRD. The likely underdiagnosis of the causes of CKD, differences in access to healthcare and regional socioeconomic inequalities are the phenomena to be tackled by organs and health managers [ 31 ].…”
Section: Discussionmentioning
confidence: 99%
“…At present, the burden and determinants of CKD have been thoroughly characterised only in high-income countries [8]. For example, in the United States (USA), there is an estimated national prevalence of CKD of 11.6% [9], although higher prevalence is observed in socio-economically disadvantaged subgroups [10,11]. Older age is the strongest predictor of CKD in the USA [12,13]; where, the prevalence of CKD in individuals over the age of 60 years is 20%, and 35% among those over 70 years [9].…”
Section: Introductionmentioning
confidence: 99%